Anticoagulant Treatment of COVID-19 as Early as Possible-Sulodexide and Perspectives. | Thromb Haemost;121(7): 849-853, 2021 07. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Anticoagulant Treatment of COVID-19 as Early as Possible-Sulodexide and Perspectives.

Schulman, Sam; Harenberg, Job.

Schulman S; Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada.
Harenberg J; Department of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.

Thromb Haemost ; 121(7): 849-853, 2021 07.

Article in English | MEDLINE | ID: covidwho-1172582

Subject(s)

Anticoagulants; COVID-19; Glycosaminoglycans; Humans; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Anticoagulants Limits: Humans Language: English Journal: Thromb Haemost Year: 2021 Document Type: Article Affiliation country: A-1477-3569

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Anticoagulants Limits: Humans Language: English Journal: Thromb Haemost Year: 2021 Document Type: Article Affiliation country: A-1477-3569